Brian I. Rini, MD, FASCO, explains why LITESPARK-012’s negative triplet results still offer lessons on drug delivery and building on first-line RCC doublets.
The final analysis confirmed PFS and response benefits in previously treated advanced clear cell renal cell carcinoma, but the OS difference did not cross the prespecified significance boundary. Brian ...
A comprehensive guide to the top data in genitourinary oncology presented at ESMO 2026. The 2026 European Society for Medical Oncology (ESMO) Annual Congress, held October 23 to 27 in Madrid, Spain, ...
Interim phase 3 data show a 58% reduction in the risk of metastasis or death with the addition of darolutamide to ADT + radiation. The phase 1/2 CELC-G-201 study found preliminary antitumor activity ...
Dr. Shawn Zimberg and Dr. Dean Laganosky discuss the BioProtect Balloon Transplant System, a rectal spacer for use in prostate cancer radiation. Laganosky: The BioProtect rectal spacing device is a ...
The Altaviva device offers a minimally invasive treatment for urge urinary incontinence, with patients returning home with therapy activated. It features a 15-year battery lifespan, MRI compatibility, ...
Women who suffer from recurrent urinary tract infections (rUTIs) are typically treated with antibiotics. These treatment regimens, however, are associated with high rates of morbidity as the world ...
CAN-2409 plus valacyclovir significantly improved DFS in localized intermediate- to high-risk prostate cancer, showing a 30% improvement over standard care. The treatment enhanced CD8+ T-cell response ...
The Edison System uses histotripsy, a non-invasive ultrasound technology, to treat kidney tumors without surgery, radiation, or systemic therapies. The #HOPE4KIDNEY trial enrolled 67 patients with non ...
Nadofaragene firadenovec offers a non-chemotherapy option for high-risk BCG-unresponsive NMIBC, transforming bladder cells into interferon-producing factories. The phase 3 trial in Japan showed a 75% ...
"We’ve achieved a lot, but the focus now must shift from cure alone to comprehensive, patient-centered care," says Vladimir Hugec, MD.
“We saw in the survey that men are concerned with how the health decisions they make now will affect them in the future,” says Petar Bajic, MD. New data from Cleveland Clinic’s MENtion It survey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results